Actively Recruiting

Age: 18Years +
All Genders
NCT04374175

SERum-bank for PANcreatic Cancer

Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-03-18

400

Participants Needed

2

Research Sites

300 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\<2cm), the chances of recovery are very good. But the main problem is there is not any detections means for this cancer. Sadly, when there is a cancer diagnostic , it's already too late in the majority of cases, because the cancer is in an advanced case. Today, there is no any effective means of detection... Blood markers can be a simple means of early detection

CONDITIONS

Official Title

SERum-bank for PANcreatic Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Documented adenocarcinoma confirmed by cytology or anatomopathology, all stages except immediately resectable tumors without preoperative cytology
  • At the start of treatment before surgery or first chemotherapy course
  • Age 18 years or older
  • Patient affiliated with or entitled to a social security system
  • For control group: Age 40 years or older
  • For control group: Undergoing digestive endoscopy for reasons other than cancer or chronic inflammatory bowel disease
  • For control group: Patient affiliated with or entitled to a social security system
Not Eligible

You will not qualify if you...

  • Patient refusal to participate
  • Acute renal failure
  • Child-Pugh B or C cirrhosis
  • Patient under guardianship or curatorship
  • Other synchronous cancer or history of cancer within the last 5 years
  • Language barrier preventing understanding or communication

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CHU Saint-Etienne

Saint-Etienne, France

Actively Recruiting

2

Institut Cancérologique Lucien Newirth (ICLN)

Saint-Priest-en-Jarez, France, 42270

Actively Recruiting

Loading map...

Research Team

N

Nicolas WILLIET, MD

CONTACT

J

Jean-Marc PHELIP, MD-PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here